Liese Barbier

Economics, Econometrics and Finance · Social Sciences

12h-index595citations69works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmaceutical Economics and Policy(36), Health Systems, Economic Evaluations, Quality of Life(31), Biosimilars and Bioanalytical Methods(31), Pharmaceutical studies and practices(12), Biomedical Ethics and Regulation(7)

Publications69 total

Identifying the use of European Public Assessment Reports (EPARs) for scientific research: a scoping review protocol
Open Science Framework·2026Open Access
A Fast Path from Innovation to Safe and Effective Medicines
Clinical Pharmacology & Therapeutics·2025Open Access
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study
BioDrugs·2025Open Access
Future-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews
Therapeutic Innovation & Regulatory Science·2025· 1 citedOpen Access
Evolving global regulatory landscape for approval of biosimilars: current challenges and opportunities for convergence
Expert Opinion on Biological Therapy·2025· 7 cited
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences
Applied Health Economics and Health Policy·2025· 1 cited
A new European platform for advancing regulatory science research
Nature Reviews Drug Discovery·2025· 4 cited
Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation
Frontiers in Medicine·2025Open Access
Do European regulatory measures accelerate national market access in Belgium? A retrospective analysis of medicines centrally authorised between 2015 and 2020
BMJ Open·2025· 1 citedOpen Access
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis
United European Gastroenterology Journal·2024· 4 citedOpen Access
PD72 Are Patient Experience Data Currently Embedded In Reimbursement Decision-Making? An Analysis Of Belgian Reimbursement Documents
International Journal of Technology Assessment in Health Care·2024Open Access
OP33 Advancing Patient Experience Data Implementation In Reimbursement Decision-Making: Insights On Challenges And Opportunities From Multistakeholder Interviews
International Journal of Technology Assessment in Health Care·2024Open Access
HPR64 Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review
Value in Health·2024Open Access
Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review
Pharmaceutical Medicine·2024· 5 citedOpen Access
Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative
Journal of Market Access & Health Policy·2024· 6 citedOpen Access
Heart Failure Patients' Perspectives on Treatment Outcomes and Unmet Medical Needs: A Qualitative Preference Study
ESC Heart Failure·2024· 2 citedOpen Access
Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment: An ISPOR Special Interest Group Report
Value in Health·2024· 1 citedOpen Access
Needs Examination, Evaluation and Dissemination (NEED): applicability to rare diseases
2024· 4 citedOpen Access
Needs Examination, Evaluation and Dissemination (NEED): applicability to rare diseases - Supplement
2024Open Access
Towards patient-centered pharmaceutical policy-making: Stakeholders’ perspectives on the Pharmaceutical Strategy for Europe
2024
page 1 of 4Next →

Frequent Co-authors

Isabelle Huys(34), Steven Simoens(22), Arnold G. Vulto(20), Rosanne Janssens(16), Paul Declerck(7), Irina Cleemput(7), Zilke Claessens(6), Evelien De Sutter(5), Yannick Vandenplas(5), Alice Vanneste(5), Elif Car(4), Isabelle Huys(4), Pascal Borry(4), Walter Van Dyck(4), Jeroen Luyten(4), Teresa Barcina Lacosta(3), Charlotte Verbeke(3), Io Wens(3), David Geerts(3), Esther van Zimmeren(3)